Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Danthron
Cat. No.:
OB0225LY-0321
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Danthron is a natural product that activates AMPK pathways.
Synonym:
Dantron; 1,8-Dihydroxyanthraquinone; Chrysazin; Antrapurol; 117-10-2; 9,10-Anthracenedione, 1,8-dihydroxy-
CAS No.:
117-10-2
Compound CID:
2950
Formula:
C14H8O4
Formula Weight:
240.21
Specification
Relative Density:
1.3032 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Danthron can be used to regulate glucose and lipid metabolism.
Library Information
Targets:
Enzymes
Receptors:
AMPK; Virus protease
Pathways:
Autophagy; Chromatin/Epigenetic; Microbiology/Virology; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-5
Plate Location:
b5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4 mg/mL; 16.65 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
